DOSEF
Price
$0.35
Change
-$0.00 (-0.00%)
Updated
Jun 18 closing price
Capitalization
2.22M
SGMT
Price
$7.04
Change
+$0.16 (+2.33%)
Updated
Jun 18 closing price
Capitalization
226.66M
67 days until earnings call
Interact to see
Advertisement

DOSEF vs SGMT

Header iconDOSEF vs SGMT Comparison
Open Charts DOSEF vs SGMTBanner chart's image
Doseology Sciences
Price$0.35
Change-$0.00 (-0.00%)
Volume$2.65K
Capitalization2.22M
Sagimet Biosciences
Price$7.04
Change+$0.16 (+2.33%)
Volume$1.2M
Capitalization226.66M
DOSEF vs SGMT Comparison Chart in %
Loading...
SGMT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
DOSEF vs. SGMT commentary
Jun 20, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DOSEF is a Hold and SGMT is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 20, 2025
Stock price -- (DOSEF: $0.35 vs. SGMT: $7.04)
Brand notoriety: DOSEF and SGMT are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: DOSEF: 59% vs. SGMT: 72%
Market capitalization -- DOSEF: $2.22M vs. SGMT: $226.66M
DOSEF [@Biotechnology] is valued at $2.22M. SGMT’s [@Biotechnology] market capitalization is $226.66M. The market cap for tickers in the [@Biotechnology] industry ranges from $335.78B to $0. The average market capitalization across the [@Biotechnology] industry is $2.38B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

DOSEF’s FA Score shows that 0 FA rating(s) are green whileSGMT’s FA Score has 0 green FA rating(s).

  • DOSEF’s FA Score: 0 green, 5 red.
  • SGMT’s FA Score: 0 green, 5 red.
According to our system of comparison, both DOSEF and SGMT are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

SGMT’s TA Score shows that 4 TA indicator(s) are bullish.

  • SGMT’s TA Score: 4 bullish, 4 bearish.

Price Growth

DOSEF (@Biotechnology) experienced а -3.77% price change this week, while SGMT (@Biotechnology) price change was +13.73% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +7.32%. For the same industry, the average monthly price growth was +13.75%, and the average quarterly price growth was +8.90%.

Reported Earning Dates

SGMT is expected to report earnings on Aug 25, 2025.

Industries' Descriptions

@Biotechnology (+7.32% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SGMT($227M) has a higher market cap than DOSEF($2.22M). DOSEF YTD gains are higher at: 149.110 vs. SGMT (56.444). DOSEF has higher annual earnings (EBITDA): -296.52K vs. SGMT (-65.55M). SGMT has more cash in the bank: 145M vs. DOSEF (820K). DOSEF has less debt than SGMT: DOSEF (0) vs SGMT (39K). DOSEF has higher revenues than SGMT: DOSEF (46.7K) vs SGMT (0).
DOSEFSGMTDOSEF / SGMT
Capitalization2.22M227M1%
EBITDA-296.52K-65.55M0%
Gain YTD149.11056.444264%
P/E RatioN/AN/A-
Revenue46.7K0-
Total Cash820K145M1%
Total Debt039K-
TECHNICAL ANALYSIS
Technical Analysis
SGMT
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
Bullish Trend 2 days ago
90%
MACD
ODDS (%)
Bullish Trend 2 days ago
88%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
83%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
86%
Advances
ODDS (%)
Bullish Trend 8 days ago
86%
Declines
ODDS (%)
Bearish Trend 3 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bullish Trend 2 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
SGMT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
AFGPX18.06N/A
N/A
Alger International Opportunities B
IASMX16.96N/A
N/A
Guinness Atkinson Asia Focus
POLIX47.14N/A
N/A
Polen Growth Institutional
ASCLX12.99N/A
N/A
AB Select US Long/Short C
BPRRX13.53N/A
N/A
Boston Partners Long/Short Rsrch Inv

DOSEF and

Correlation & Price change

A.I.dvisor tells us that DOSEF and MNPR have been poorly correlated (+24% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that DOSEF and MNPR's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DOSEF
1D Price
Change %
DOSEF100%
+0.23%
MNPR - DOSEF
24%
Poorly correlated
-3.23%
AKRO - DOSEF
23%
Poorly correlated
-0.90%
SGMT - DOSEF
21%
Poorly correlated
+2.33%
ADAG - DOSEF
21%
Poorly correlated
+1.56%
CLRPF - DOSEF
12%
Poorly correlated
+0.68%
More

SGMT and

Correlation & Price change

A.I.dvisor indicates that over the last year, SGMT has been loosely correlated with CCCC. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if SGMT jumps, then CCCC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SGMT
1D Price
Change %
SGMT100%
+2.33%
CCCC - SGMT
43%
Loosely correlated
-3.36%
TERN - SGMT
40%
Loosely correlated
+2.56%
VRDN - SGMT
40%
Loosely correlated
+1.11%
CRBU - SGMT
40%
Loosely correlated
+10.34%
STOK - SGMT
38%
Loosely correlated
-0.77%
More